Search Within

Darren Richard Feldman

Formats
  1. Journal Article (189)
  2. Meeting Abstract (142)
  3. Book Section (6)
  4. Review (6)
  5. Guidelines (2)
  6. Research Letter (2)
  7. Correspondence (1)
  8. Editorial (1)
Groups
  1. Department of Medicine (349)
  2. Genitourinary Oncology Service (349)
  3. Solid Tumor Oncology Division (349)
  4. Survivorship Research (125)
  5. Surgery (114)
  6. Epidemiology and Biostatistics (112)

More Groups

People
  1. Robert Motzer (158)
  2. George Bosl (86)
  3. Martin Voss (81)
  4. Sujata Patil (81)
  5. Joel Sheinfeld (68)
  6. Chung-Han Lee (55)

More People

Years
  1. 2025 (16)
  2. 2024 (24)
  3. 2023 (20)
  4. 2022 (21)
  5. 2021 (25)
  6. 2020 (21)

More Years

Publications
  1. Journal of Clinical Oncology (148)
  2. Urology (13)
  3. Clinical Genitourinary Cancer (11)
  4. Cancer (10)
  5. Clinical Cancer Research (9)
  6. Investigational New Drugs (7)

More Publications

Publishers
  1. American Society of Clinical Oncology (154)
  2. Elsevier Science, Inc. (29)
  3. Elsevier Inc. (28)
  4. Wiley Blackwell (20)
  5. Oxford University Press (18)
  6. American Association for Cancer Research (17)

More Publishers

Results (349)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Post-transplant pain and paralysis: Neurologic amyotrophy as an atypical cause of shoulder dysfunction following hematopoietic stem cell transplant
    Meeting Abstract

    Davidoff, C.; Ibanez, K.; Hwang, S.; Goldstein, I.; Feldman, D. R.; Gyurkocza, B.; Giralt, S. A.; Politikos, I.; Ponce, D. M.; Scordo, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Clinical outcomes in NF2-mutated RCC treated with contemporary immunotherapy regimens
    Meeting Abstract

    Fitzgerald, K. N.; Duzgol, C.; Knezevic, A.; Jacobi, R.; Kotecha, R. R.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; more...
    Cancer Research (2023)

    Fulltext@MSK | Save
  • Ototoxicity associated with high-dose carboplatin for patients with previously treated germ cell tumors
    Journal Article

    Funt, S. A.; Knezevic, A.; Wilson, K.; Bromberg, M.; Budnick, A.; O’Connor, K. L.; McHugh, D. J.; Larsen, E.; Bajorin, D. F.; Motzer, R. J.; more...
    Cancer (2023)

    Fulltext@MSK | Save
  • P3BEP (ANZUP 1302): An international randomized phase 3 trial of accelerated versus standard BEP chemotherapy for male and female adults and children with intermediate and poor-risk metastatic germ cell tumours (GCTs)
    Meeting Abstract

    Zebic, D. S.; Tran, B.; Martin, A. J.; Pashankar, F. D.; Mazhar, D.; Huddart, R. A.; Wheater, M.; Walpole, E. T.; Dunwoodie, E.; Feldman, D. R.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • First-in-human clinical trial design of a first-in-class theranostic approach with a peptide-based radioligand targeting CA IX-expressing tumors
    Meeting Abstract

    Feldman, D. R.; Tran, B.; Emmett, L.; Hofman, M. S.; Olivier, P.; Mahammedi, H.; Galetic, I.; Pokorska-Bocci, A.; Bouisset, F.; Gollmer, K.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • The impact of population pharmacogenomics and risk allele frequencies on cisplatin-induced peripheral sensory neuropathy (PSN)
    Meeting Abstract

    Nakshatri, S.; Dinh, P. C.; Feldman, D. R.; Hamilton, R. J.; Vaughn, D. J.; Fung, C.; Kollmannsberger, C. K.; Huddart, R. A.; Martin, N. E.; Einhorn, L. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • A single-arm, phase II study of durvalumab (D) and tremelimumab (T) for relapsed/refractory germ cell tumors (GCT)
    Meeting Abstract

    Funt, S. A.; Knezevic, A.; Freeman, B. A.; Bolos, M.; Martorana, V.; Donoghue, M.; Khan, S.; Singh, H.; Bromberg, M.; Quinlan, C.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Associations of diet with survival of patients (pts) with metastatic cancer of the urothelium (mUC) and renal cell carcinoma (mRCC) on immune checkpoint blockade (ICB)
    Meeting Abstract

    Guercio, B. J.; Ratna, N.; Gavrilov, D.; Duzgol, C.; Akhlaq, M.; Teo, M. Y.; Regazzi, A. M.; Kotecha, R. R.; Funt, S. A.; Aggen, D. H.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Germline mutations in hereditary renal cell carcinoma (RCC) genes among 32,240 patients with all cancer types
    Meeting Abstract

    Carlo, M. I.; Schroeder, A.; Mukherjee, S.; Kemel, Y.; Kotecha, R. R.; Lee, C. H.; Shah, N. J.; Feldman, D. R.; Liu, Y. L.; Walsh, M. F.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save
  • Genomic determinants of progression-free survival after second line of therapy (PFS-2) for patients on immunotherapy-based combination therapies for advanced clear cell renal cell carcinoma
    Meeting Abstract

    Fitzgerald, K. N.; Kotecha, R. R.; Knezevic, A.; Shapnik, N.; Aggen, D. H.; Carlo, M. I.; Shah, N. J.; Voss, M. H.; Feldman, D. R.; Motzer, R. J.; more...
    Journal of Clinical Oncology (2023)

    Fulltext@MSK | Save